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We recently showed that dendritic cells (DCs) activated by thymic stromal lymphopoietin 
(TSLP) prime naive CD4
 
 
 
 T cells to differentiate into T helper type 2 (Th2) cells that 
produced high amounts of tumor necrosis factor-
 
 
 
 (TNF-
 
 
 
), but no interleukin (IL)-10. 
Here we report that TSLP induced human DCs to express OX40 ligand (OX40L) but not 
IL-12. TSLP-induced OX40L on DCs was required for triggering naive CD4
 
 
 
 T cells to 
produce IL-4, -5, and -13. We further revealed the following three novel functional 
properties of OX40L: (a) OX40L selectively promoted TNF-
 
 
 
, but inhibited IL-10 production 
in developing Th2 cells; (b) OX40L lost the ability to polarize Th2 cells in the presence of 
IL-12; and (c) OX40L exacerbated IL-12–induced Th1 cell inflammation by promoting 
TNF-
 
 
 
, while inhibiting IL-10. We conclude that OX40L on TSLP-activated DCs triggers Th2 
cell polarization in the absence of IL-12, and propose that OX40L can switch IL-10–producing 
regulatory Th cell responses into TNF-
 
 
 
–producing inflammatory Th cell responses.
 
CD4
 
 
 
 Th2 cells are historically defined as effec-
tor T cells with the capacity to produce IL-4, -5,
-10, and -13 (1, 2). Th2 cells are critical for the
development of antibody responses against ex-
tracellular parasitic infection and of aller-
gic immune responses to allergens. However,
there are characteristics of conventional Th2
cells that seem to preclude their involvement
in allergic inflammation. First, IL-10 does not
appear to contribute to allergic inflammation
in either humans or mice (3–5); in fact, many
studies have demonstrated that IL-10 suppresses
allergic inflammation (6–9). Second, in animal
models, low affinity–altered peptides that have
been used to prime Th2 cell responses do not
cause allergic inflammation, but rather induce
tolerance (10, 11). Third, historically, although
IFN-
 
 
 
–producing Th1 cells are defined as in-
flammatory, Th2 cells that produce IL-4, -5, -10,
and -13 are defined as antiinflammatory (12).
Thus, it is difficult conceptually and experimen-
tally to comprehend how antiinflammatory Th2
cell is involved in the development of allergic
inflammation.
We recently described a new type of human
Th2 cell that produces the classic Th2 cytokines
IL-4, -5, and -13, but not IL-10 (13). Remark-
ably, these Th2 cells produce very high lev-
els of TNF-
 
 
 
. These TNF-
 
 
 
–highly positive
(TNF-
 
 
 
2
 
 
 
), IL-10–negative (IL-10
 
 
 
) inflamma-
tory Th2 cells were originally generated from
human CD4
 
 
 
 naive T cells cultured with alloge-
neic myeloid DCs (mDCs) activated by human
thymic stromal lymphopoietin (TSLP), an IL-7–
like cytokine (13). We believe, therefore, these
TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 Th2 cells most likely represent
the pathogenic Th2 cells that cause allergic in-
flammation, in contrast to the conventional
IL-10–producing Th2 cells.
We found that TSLP is expressed by kera-
tinocytes of atopic dermatitis (13). TSLP ex-
pression is also associated with Langerhans cell
migration and activation in situ (13). These
findings suggest that allergic insults from
chemicals, microbes, or allergens initially cause
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mucosal epithelial cells or skin keratinocytes to produce
TSLP. TSLP then activates epidermal–dermal DCs to mi-
grate into the draining lymph nodes and to prime allergen-
specific naive T cells to expand and differentiate into in-
flammatory TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 Th2 cells, which ultimately
contribute to the induction of allergic inflammation.
To determine how TSLP-activated DCs (TSLP-DCs) in-
duce TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 inflammatory Th2 cell differentiation,
we performed microarray global gene expression analyses of
freshly isolated peripheral blood mDCs and mDCs activated
by TSLP and poly I:C. We found that TSLP stimulated
mDCs to express the OX40 ligand (OX40L), which is a
member of the TNF superfamily that has been implicated in
the B cell–T cell interaction (14), the DC–T cell interaction
(15, 16), and the initiation of Th2 cell responses (15–18).
In this study, we showed that the OX40L expressed by
TSLP-DCs induces naive CD4
 
 
 
 T cells to differentiate into
TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 inflammatory Th2 cells in the absence of
IL-12. OX40L also converted an IL-10–producing regulatory
Th1 cell response induced by IL-12 into a TNF-
 
 
 
–produc-
ing inflammatory Th1 cell response. This therefore indicated
that OX40L serves as the TSLP-DC–derived original Th2
cell–polarizing signal that operates in an IL-12 default fash-
ion. We also demonstrated that OX40L acts as a switch that
inhibits IL-10 but promotes TNF-
 
 
 
 in both Th1 and Th2
cell responses. We propose that Th1 and Th2 cell responses
be divided into inflammatory and regulatory subtypes.
 
RESULTS
TSLP activates DCs to express OX40L 
but not proinflammatory cytokines
 
To search for the molecular mechanism by which TSLP-
DCs induce naive CD4
 
 
 
 T cells to differentiate into TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 inflammatory Th2 cells, we performed human
Figure 1. TSLP-DCs express OX40L. (A) Each column represents data 
from human blood CD11c  immature mDCs either resting or activated 
by poly I:C or TSLP. The selected 2,166 genes were grouped, based on 
similarity in expression patterns, by hierarchical clustering as described 
in Materials and methods. Each row represents relative hybridization 
intensities of a particular gene across different samples. Colors reflect 
the magnitude of relative expression of a particular gene across samples. 
Cluster I, II, and III include genes highly expressed in poly I:C–activated 
DCs, resting DCs, and TSLP-activated DCs, respectively. Cluster IV includes 
genes highly expressed in both poly I:C–activated and TSLP-activated 
DCs. Under culture with different stimuli, expression profiles of the indi-
cated genes (B) and OX40L mRNA expression (C) in DCs were analyzed at 
the 24-h time point by microarray and RT-PCR, respectively, and surface 
expression of OX40L on DCs were analyzed at the 48-h time point by 
flow cytometry (D). OX40L expression on TSLP-DCs were monitored at 
different time points (E). The staining profile of anti-OX40L mAb and 
isotype-matched control are shown by the shaded and open areas, 
respectively. The results of the gene expression profiles (B) are shown 
as the relative hybridization intensity level by microarray analysis. 
Accession number of each microarray dataset are available at http://
www.ncbi.nih.gov/entrez/query.fcgi?db=gene. 
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Affymetrix microarray gene expression analyses in human
peripheral blood CD11c
 
 
 
 immature mDCs either resting or
activated by TSLP or poly I:C. The resulting gene expres-
sion data were organized on the basis of the overall similarity
in the gene expression patterns by using an unsupervised hi-
erarchical clustering algorithm of 2,166 out of 38,500 well-
Figure 2. TSLP-DC-mediated inflammatory Th2 cell response requires 
OX40L as a positive Th2 cell–polarizing signal and default of a lack of 
IL-12. CD4  naive T cells were cocultured with med-DCs (A), poly I:C-DCs (B), 
or TSLP-DCs (C and D) for 7 d in the presence of the indicated neutralizing Abs 
or recombinant IL-12. Cytokine production by T cells was analyzed intracellu-
larly by flow cytometry (A–C) and measured in supernatants after restimula-
tion with anti-CD3 and anti-CD28 mAbs for 24 h by ELISA (D). Percentages of 
the respective cytokine-producing T cells are indicated in each dot blot profile 
in A–C. Error bars in D represent standard deviations of triplicate cultures. Data 
are from one of four independent experiments. 
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characterized genes (Fig. 1 A). Distinct clusters were identi-
fied: Cluster I included genes highly expressed by DCs acti-
vated by poly I:C (poly I:C-DCs); cluster II included genes
highly expressed in resting DCs and down-regulated during
activation; cluster III included genes highly expressed in DCs
activated by TSLP; and cluster IV included genes highly ex-
pressed in DCs activated by both poly I:C and TSLP. The rel-
ative expression levels of the genes involved in T cell activa-
tion, polarization, and chemotaxis are shown in Fig. 1 B.
We additionally confirmed and extended our previous
conclusion that unlike Toll-like receptor (TLR) ligands and
the CD40 ligand (CD40L), TSLP does not stimulate DCs to
produce Th1 cell–polarizing cytokines, such as IL-12, IL-23,
IL-27, IFN-
 
 
 
, IFN-
 
 
 
, and IFN-
 
 
 
, or proinflammatory cy-
tokines, such as IL-6 and TNF-
 
 
 
 as well as IFN-inducible
protein 10 (IP-10/CXCL10) and monokine induced by
IFN-
 
 
 
 (MIG/CXCL9) (Fig. 1 B) (13). We found that TSLP
did not stimulate DCs to produce the Th2-polarizing cyto-
kine IL-4 and antiinflammatory cytokine IL-10. However,
TSLP induced DCs to produce high levels of Th2 cell–
attracting chemokines thymus and activation-regulated che-
mokine (TARC/CCL17) and macrophage-derived chemo-
kine (MDC/CCL22), as well as IL-8 and IL-15. In contrast,
triggering of TLR3 by poly I:C strongly induced mDCs to
produce all the Th1 cell–polarizing cytokines and proinflam-
matory cytokines (Fig. 1 B) but few Th2 cell–attracting che-
mokines. Although both TSLP and poly I:C induced mDCs
to up-regulate the expression of costimulatory molecules,
including CD40, CD80 and CD86, TSLP preferentially
induced mDC to express the mRNA for OX40L (Fig. 1, A
and B), a member of the TNF superfamily that has been im-
plicated in the initiation of Th2 cell responses (15–18).
This expression of OX40L by TSLP-DCs was confirmed by
RT-PCR (Fig. 1 C) and flow cytometry analyses using
anti-OX40L mAbs (Fig. 1 D). The induction of OX40L
on mDC surface by TSLP was detectable by 12 h and
reached a maximal level during 48–72 h after TSLP activa-
tion (Fig. 1 E).
 
TSLP-DCs use OX40L to generate TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 
inflammatory Th2 cells 
 
Because an OX40–OX40L interaction has been implicated in
the triggering of Th2 cell immune responses in both human
and mice (15–18), we investigated whether OX40L is the
Th2 cell–polarizing signal from TSLP-DCs. Although naive
CD4
 
 
 
 T cells primed by DCs cultured in the absence of
TSLP (med-DCs) produced low levels of both Th1 cytokine
(IFN-
 
 
 
) and Th2 cytokines (IL-4, -5, and -13) (Fig. 2 A, col-
umn I) and CD4
 
 
 
 T cells primed by poly I:C-DCs produced
less Th2 cytokines and a large amount of the Th1 cytokine
IFN-
 
 
 
 (Fig. 2 B, column I), CD4
 
 
 
 T cells primed by TSLP-
DCs produced large amounts of Th2 cytokines IL-4, IL-5,
and IL-13, but lower Th1 cytokine IFN-
 
 
 
 (Fig. 2 C, column
I). Furthermore, TSLP-DCs induced naive CD4
 
 
 
 T cells to
produce large amount of TNF-
 
 
 
 but no IL-10 (Fig. 2 C, col-
umn I). A neutralizing anti-OX40L mAb did not have sub-
stantial effects on the cytokine production by CD4
 
 
 
 T cells
primed by med-DCs (Fig. 2 A, column II) or by poly I:C-
DCs (Fig. 2 B, column II). In contrast, anti-OX40L mAb
strongly inhibited IL-4, -5, and -13 production and promoted
IFN-
 
 
 
 production by CD4
 
 
 
 T cells primed by TSLP-DCs
(Fig. 2, C [column II] and D). This demonstrates that OX40L
represents the Th2 cell–polarizing signal from TSLP-DCs.
Most strikingly, the anti-OX40L mAb dramatically in-
hibited TNF-
 
 
 
 production, but promoted IL-10 production
by CD4
 
 
 
 T cells primed by TSLP-DCs (Fig. 2, C [column
II] and D). These data suggest that OX40L expressed by
TSLP-DCs is responsible for not only polarizing naive
CD4
 
 
 
 T cells into Th2 cells, but also endowing the Th2
cells with a TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 inflammatory phenotype.
 
IL-4 has no effect on TNF-
 
 
 
 and IL-10
 
IL-4 has been suggested as the classic Th2 cell polarizing sig-
nal (1, 15, 19). However, because IL-4 is the major cytokine
produced by Th2 cells themselves and human antigen-pre-
senting cells including DCs activated by TSLP and other
stimuli do not produce IL-4 (Fig. 1 B) (13), it has been sug-
gested that IL-4 is not the original trigger of Th2 cell re-
sponses. To determine the function of IL-4 in the genera-
Figure 3. Relationship between cytokine production and cell division 
in T cells primed with TSLP-DCs. CFSE-labeled CD4  naive T cells were 
primed with TSLP-DCs in the presence of an anti-OX40L mAb, an anti–IL-4 
mAb, or recombinant IL-12 for 7 d, and then intracellular cytokines were 
analyzed by flow cytometry. Numbers in each dot blot profile indicate the 
percentages of the respective cytokine-producing T cells. Data are from 
one of three independent experiments. 
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tion of inflammatory TNF-
 
 
 
2
 
 
 
IL-10
 
 
 
 Th2 cells induced by
TSLP-DCs, we added a neutralizing anti–IL-4 mAb at the
beginning of the coculture of naive CD4
 
 
 
 T cells and alloge-
neic TSLP-DCs. We found that, as with anti-OX40L mAb,
anti–IL-4 mAb decreased the frequency with which Th2 cells
produced IL-4, -5, and -13, but concomitantly increased the
frequency with which cells produced IFN-
 
 
 
 (Fig. 2 C, col-
umn III). However, unlike anti-OX40L mAb, anti–IL-4
mAb had no effect on TNF-
 
 
 
 or IL-10 production by T cells
cultured with TSLP-DCs (Fig. 2, C [column III] and D).
 
Synergy between DC-derived OX40L and T cell–derived IL-4
 
Because anti-OX40L mAb or anti–IL-4 mAb alone only
partially blocked the generation of Th2 cells that produced
IL-4, -5 and -13, we further investigated whether the com-
bination of anti-OX40L and anti–IL-4 mAbs would com-
pletely block the generation of Th2 cells induced by TSLP-
DCs. Indeed, we found a synergistic effect of anti-OX40L
and anti–IL-4 mAbs: the combination of both almost com-
pletely switched a Th2 cell response to a Th1 cell response
(Fig. 2, C [column IV] and D). Because TSLP-DCs do
not produce IL-4, this experiment suggested that whereas
OX40L is the original Th2 cell–polarizing signal from
TSLP-DCs, IL-4 is a critical autocrine stabilizer and en-
hancer of the developing Th2 cells. It appears that OX40L
and IL-4 may work synergistically and sequentially in driving
Th2 cell responses in T cell and TSLP-DC coculture.
 
IL-12 is dominant over OX40L 
 
Because TSLP does not induce human mDCs to produce Th1
cell–polarizing signal IL-12 (13) (Fig. 1 B), we further investi-
gated whether the ability of OX40L expressed by mDCs to in-
duce Th2 cell responses depends on a default mechanism of no
IL-12. We performed two experiments. First, we added exoge-
nous IL-12 into the coculture of naive CD4
 
 
 
 T cells and
TSLP-DCs and found that exogenous IL-12 markedly inhib-
ited the generation of Th2 cells, but strongly polarized T cell
differentiation toward to Th1 cell (Fig. 2, C [column V] and
D). Exogenous IL-12 also induced a strong Th1 cell polariza-
tion of naive CD4
 
 
 
 T cells primed with DCs nonactivated by
TSLP (med-DCs) (Fig. 2 A, column III), and neutralizing anti–
IL-12 Ab inhibited the generation of Th1 cells induced by poly
I:C-DCs (Fig. 2 B, column III). Second, we added neutralizing
anti-CD40L mAb to block the ability of activated T cells to in-
duce mDCs to produce endogenous IL-12 through CD40L
during the cognate T cell and TSLP-DC interaction. We found
that anti-CD40L mAb completely blocked the generation of
residual Th1 cells and further promoted Th2 cell differentiation
in the coculture of CD4
 
 
 
 T cells and TSLP-DCs (Fig. 2, C
[column VI] and D). The results of these two experiments sug-
Figure 4. TSLP-DCs further promote the generation of Th2 cells 
without inducing IL-10 production after two rounds of stimulation. 
CD4  naive T cells were stimulated by TSLP-DCs for 7 d (one cycle of stim-
ulation), and then these differentiated CD4  T cells were restimulated by 
TSLP-DCs from the same allogeneic donor for further 7 d (two cycles of 
stimulation) in the presence or absence of anti-OX40L mAbs. Cytokine 
production by these two types of CD4  T cells was analyzed intracellularly 
by flow cytometry (A) and measured in supernatants after restimulation 
with anti-CD3 and anti-CD28 mAbs for 24 h by ELISA (B). Percentages of 
the respective cytokine-producing T cells are indicated in each dot blot 
profile in A. Error bars in B represent standard deviations of triplicate 
cultures. Data are from one of three independent experiments. 
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gest that the ability of TSLP-DCs to induce Th2 cell differenti-
ation depends on a positive Th2 cell–polarizing signal, namely,
OX40L, and a default mechanism of low or absent IL-12.
 
IL-10–producing T cells are not generated by default 
T cell activation
 
Because OX40L has been shown to be critical for the prolif-
eration and survival of activated T cells (20, 21), it is possible
that anti-OX40L mAb allows the generation of IL-10–pro-
ducing T cells by arresting T cell proliferation induced by
TSLP-DCs. To test this possibility, naive CD4
 
 
 
 T cells were
labeled with CFSE, and then cultured with allogeneic TSLP-
DCs in the presence of anti-OX40L mAb, anti–IL-4 mAb, or
isotype control mAb and IL-12 for 7 d. Unlike the TNF-
 
 
 
-
and IFN-
 
 
 
–producing T cells, the IL-10–producing T cells
generated in the presence of anti-OX40L mAb all underwent
at least seven divisions (Fig. 3), suggesting that the generation
of IL-10–producing T cells is not the result of T cell prolifer-
ation arrest caused by the blockade of OX40L.
 
TSLP-DCs fail to induce Th2 cells to produce IL-10 after two 
rounds of stimulation
 
Complete differentiation of Th1 and Th2 cells requires two
cycles of stimulation, and the differentiation of IL-10- and
IFN-
 
 
 
-double producing T cells also requires extensive ex-
pansion induced by IL-12 for several weeks (22, 23). To ex-
clude the possibility that TSLP-DCs could induce IL-10–
producing conventional Th2 cells after extended clonal
expansion, we analyzed the cytokine production by CD4
 
 
 
 T
cells after two rounds of stimulation by TSLP-DCs. We
found that, when compared with the single cycle stimulation
by TSLP-DCs, two cycles of stimulation further promoted
the CD4
 
 
 
 T cells to produce IL-4, IL-5, IL-13, and TNF-
 
 
 
without inducing IL-10 production (Fig. 4, A and B). The
addition of an anti-OX40L mAb during the two rounds of
stimulation strongly inhibited CD4
 
 
 
 T cells to produced
IL-4, IL-5, IL-13, and TNF-
 
 
 
, but concomitantly promoted
CD4
 
 
 
 T cells to produce IL-10 and IFN-
 
 
 
. These results
suggest that the ability of TSLP-DCs to induce the genera-
tion of TNF-
 
 2 IL-10  inflammatory Th2 cells from naive
CD4  T cells through OX40L is not caused by the differen-
tial kinetics of IL-10 production by the activated T cells.
The IL-4 /IL-13  Th2 cells induced by TSLP-DCs express 
TNF-  but not IL-10, as analyzed by three-color 
intracellular cytokine staining
To further confirm that TSLP-DCs induced naive CD4  T
cells to differentiate into TNF- 2 IL-10  inflammatory Th2
cells, we performed three-color intracellular cytokine stain-
ing. Fig. 5 shows that, after a 6-h restimulation of CD4  T
cells primed with TSLP-DCs,  25% of CD4  T cells ex-
pressed IL-4 and 48% of T cells expressed IL-13 (top). None
of these IL-4– or IL-13–producing CD4  T cells expressed
IL-10. In contrast, over two thirds of the IL-4– or IL-13–
producing CD4  T cells expressed TNF-  (Fig. 5, middle).
Interestingly, while all the IL-4-expressing CD4  T cells ex-
pressed IL-13,  50% of the IL-13–producing T cells did not
express IL-4 (Fig. 5, bottom). These data confirm that the
majority of the Th2 cells induced by TSLP-DCs are TNF-
 2 IL-10  inflammatory Th2 cells, although these Th2 cells
may produce IL-13 or both IL-13 and IL-4.
Recombinant OX40L induces inflammatory 
Th2 cell responses
To further confirm the effects of the OX40L expressed
by TSLP-DCs in polarizing TNF- 2 IL-10  inflammatory
Th2 cell responses, we cultured naive CD4  T cells in the
presence of anti-CD3 and anti-CD28 mAbs with parental L
cells or OX40L-transfected L cells. After 7 d of culture, the
primed CD4  T cells were then examined for their ability to
produce cytokines by intracellular staining (Fig. 6 A) and
ELISA analysis of the culture supernatants after restimulation
with anti-CD3 and anti-CD28 mAbs (Fig. 6 B). OX40L
strongly primed naive CD4  T cells to produce the Th2 cy-
tokines IL-4, -5, and -13 and the inflammatory cytokine
TNF- , but little IFN-  and IL-10 (Fig. 6, A [column II]
and B). These data confirm our conclusion that OX40L is
the downstream molecule from TSLP-DCs that induces
TNF- 2 IL-10  inflammatory Th2 cell responses.
Recombinant OX40L enhances TNF-  production and inhibits 
IL-10 production by the conventional Th2 cells induced by IL-4
Previous studies have demonstrated that IL-4 plus anti-CD3
and anti-CD28 mAbs can induce naive CD4  T cells to dif-
Figure 5. Th2 cells induced by TSLP-DCs coexpress TNF-  but not 
IL-10, as analyzed by three-color intracellular cytokine staining. Naive 
CD4  T cells were primed with TSLP-DCs for 7 d, and then cytokine production 
by the CD4  T cells was analyzed intracellularly by flow cytometry using three 
patterns of triple-color staining as follows: (a) FITC-labeled anti–TNF-    PE-
labeled anti–IL-4   APC-labeled anti–IL-10; (b) FITC-labeled anti–TNF-    
PE-labeled anti–IL-13   APC-labeled anti–IL-10; and (c) FITC-labeled anti–
TNF-    PE-labeled anti–IL-13   Alexa Fluor 647-labeled anti–IL-4. Percent-
ages of the respective cytokine-producing T cells are indicated in each dot blot 
profile. Data are from one of three independent experiments.JEM VOL. 202, November 7, 2005 1219
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ferentiate into the conventional Th2 cells producing IL-4,
-5, -13, and -10 (24, 25). We confirmed these published
data by culturing naive CD4  T cells with IL-4 and anti-
CD3 and anti-CD28 mAbs (Fig. 6, A [column III] and B).
OX40L strongly promoted the conventional Th2 cells in-
duced by IL-4 to produce more IL-4, -5, and -13, but less
IFN-  (Fig. 6, A [column IV] and B). Most importantly,
OX40L promoted TNF-  production while shutting down
IL-10 production by the conventional Th2 cells induced by
IL-4. This experiment further demonstrated that OX40L is a
master switch that converts a conventional IL-10–producing
Th2 cell response induced by IL-4 into a TNF- –producing
inflammatory Th2 cell response.
Recombinant OX40L enhances TNF-  production 
and inhibits IL-10 production by Th1 cells
Although OX40L expressed by TSLP-DCs failed to induce
a Th2 cell response in the presence of IL-12, the question
raised here is whether OX40L can change the quality of Th1
cell response induced by IL-12. We therefore cultured naive
CD4  T cells in the presence of anti-CD3 and anti-CD28
mAbs and IL-12 in the presence or absence of OX40L. Na-
ive CD4  T cells cultured with anti-CD3 and anti-CD28
mAbs and with IL-12 differentiated into conventional Th1
cells that produce IFN- , TNF- , and IL-10 (Fig. 6, A [col-
umn V] and B), which is consistent with previous studies
(24, 26). The addition of OX40L to the above Th1 cell cul-
ture did not induce the cultured T cells to produce IL-4, -5,
and -13, but it strongly promoted the production of TNF- 
and IFN-  while inhibiting IL-10 production by the devel-
oping Th1 cells (Fig. 6, A [column V] and B).
OX40L increases GATA-3 and c-Maf in T cells cultured 
with TSLP-DCs
Th1 and Th2 cell differentiation is regulated by key tran-
scriptional factors such as T-bet for Th1 and GATA-3 and
c-Maf for Th2 (19). Because Th1 cells express high T-bet
but low GATA-3 and c-Maf and Th2 cells express low
T-bet but high GATA-3 and c-Maf, these transcriptional
factors can be used as a molecular makers for Th1 or Th2
cell differentiation. We therefore examined the kinetics of
GATA-3, c-Maf, and T-bet expression by quantitative
PCR in CD4  T cells primed by med-DCs, TSLP-DCs, or
poly I:C-DCs, respectively. Although CD4  T cells that
Figure 6. OX40L-transfected L cells enhance TNF-  production 
and inhibit IL-10 production in T cells. CD4  naive T cells were cultured 
with anti-CD3 and anti-CD28 mAbs on OX40L-transfected L cells and/or 
the indicated recombinant cytokines for 7 d. Cytokine production by CD4  
T cells was analyzed intracellularly by flow cytometry (A) and measured in 
supernatants after restimulation with anti-CD3 and anti-CD28 mAbs for 
24 h by ELISA (B). Percentages of the respective cytokine-producing T cells 
are indicated in each dot blot profile in A. Error bars in B represent standard 
deviations of triplicate cultures. Data are from one of four independent 
experiments.NOVEL FUNCTION OF OX40L EXPRESSED BY TSLP-ACTIVATED DCS | Ito et al. 1220
were primed by inactivated DCs (med-DCs) expressed low
levels of GATA-3, c-Maf, and T-bet at any time points af-
ter priming (Fig. 7 A), the addition of IL-12 strongly up-
regulated T-bet expression in the primed CD4  T cells
(Fig. 7 B). In contrast, CD4  T cells primed by TSLP-DCs
expressed high levels of GATA-3 and c-Maf, but low T-bet
(Fig. 7, A and B). Adding anti-OX40L mAb or anti–IL-4
mAb greatly reduced GATA-3 and c-Maf expression (Fig. 7
B), confirming that the Th2 cell polarization induced by
TSLP-DCs is mediated by OX40L and IL-4. However,
adding IL-12 into the CD4  T cell that was primed with
TSLP-DCs strongly inhibited GATA-3 and c-Maf, while
strongly up-regulating T-bet expression (Fig. 7 B). This
confirms that the ability of IL-12 to induce Th1 cells is
dominant over the ability of OX40L to induce Th2 cells. In
contrast to TSLP-DCs, poly I:C-DCs induced naive CD4 
T cells to express T-bet, but neither GATA-3 nor c-Maf
(Fig. 7, A and B). The ability of poly I:C-DCs to induce
T-bet in naive CD4  T cells was inhibited by anti–IL-12
mAb (Fig. 7 B).
These data suggest that the expression of T-bet or
GATA-3 and c-Maf can be used as molecular markers for
Th1 or Th2 cell differentiation. OX40L expressed by TSLP-
DCs induced the expression of two transcriptional factors
GATA-3 and c-Maf in T cells, further supporting their criti-
cal roles in Th2 cell polarization.
DISCUSSION
We previously demonstrated that TSLP strongly activates
human mDCs to up-regulate major histocompatibility classes
I and II and costimulatory molecules CD40, CD80, CD83,
and CD86 (13). However, unlike conventional DC activa-
tion signals such as ligands for different TLRs and CD40L,
TSLP does not induce mDCs to secrete proinflammatory/
Th1-inducing cytokines such as IL-1 / , IL-6, IL-12, IL-
23, IL-27, or TNF- . These findings suggest that TSLP ac-
tivates mDCs through a pathway that is independent of
TLR–IL-1R–MyD88 or CD40–TRAF-6 signaling pathways,
which is consistent with recent findings regarding the signal-
ing pathways underlying Th2 cell development (27–29).
Our findings also suggest that the absence of IL-12 produc-
tion by TSLP-DCs creates a permissive condition in which a
positive Th2 cell–polarizing signal from TSLP-DCs can in-
duce Th2 cell responses.
By using a neutralizing monoclonal antibody to OX40L
and recombinant OX40L, we demonstrated that OX40L is
the molecule downstream from TSLP-DCs that induces na-
ive CD4  T cells to differentiate into TNF- 2 IL-10  in-
flammatory Th2 cells. Because TSLP-DCs do not produce
detectable IL-4 at both mRNA and protein levels, our study
suggests that OX40L represent the initial signal from DCs
for polarizing naive CD4  T cells to Th2 cells. Although
many previous studies suggest a critical role of OX40–
OX40L interaction in driving Th2 cell responses (15–18),
the concept of OX40L being a Th2 cell–polarizing factor
has been questioned by many in vivo studies showing that
blocking OX40–OX40L interaction inhibits the develop-
ment or decreases the severity of Th1 cell–mediated autoim-
mune diseases (30–33). This can now be explained by our
study showing that OX40L is unable to induce Th2 cell re-
sponse in the presence of IL-12. In contrast, OX40L has the
ability to promote IL-12–mediated Th1 autoimmunity by
enhancing TNF-  and IFN-  production while inhibiting
IL-10 production. OX40L may also contribute to promote
Th1 cell–mediated autoimmunity by prolonging the survival
and proliferation of Th1 memory and effector cells and by
enhancing the effector functions of CD8  T cells (34–36). 
It has been suggested that Th2 cell differentiation is a
simple default fate, which occurs in the absence of Th1 cell–
polarizing signals (37). However, IL-12 deficiency does not
result in a spontaneous Th2 cell response, suggesting that the
development of a Th2 cell response is not a simple default
fate (27). Our current study suggests that the development of
a Th2 cell response depends on a Th2 cell–polarizing signal
OX40L, as well as a default mechanism of no IL-12. Only
TSLP, but not CD40L or poly I:C, can stimulate DCs to
provide both. The current finding that a Th1 cell–polarizing
factor IL-12 is dominant over a Th2 cell–polarizing factor
OX40L may also provide an explanation at the molecular
level for the “hygiene theory” of atopy.
Historically, Th2 cells have been defined as CD4  T
cells that have the ability to produce IL-4, IL-5, IL-10, and
IL-13, and Th1 cells have been defined as CD4  T cells that
Figure 7. OX40L expressed by TSLP-DCs induces the expression 
of GATA-3 and c-Maf in T cells. Expression levels of transcriptional 
factors involved in Th1 and Th2 cell differentiation—T-bet, GATA-3, and 
c-Maf—were quantitatively measured by real-time PCR in CD4  T cells 
primed with med-DCs, TSLP-DCs, and poly I:C-DCs in the presence of the 
indicated neutralizing mAb or recombinant IL-12 at different time points 
(A) or after a 7 d-culture (B). The amounts of mRNA were shown by arbitrary 
units relative to the amount of 18s mRNA. Representative data of three 
independent experiments are shown.JEM VOL. 202, November 7, 2005 1221
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have the ability to produce IFN-  and sometimes TNF- 
(1, 2). However, many studies have demonstrated that IL-10
is not involved in Th2 cell–mediated allergic inflammation
(3–5), by contrast it inhibits allergic diseases in animal mod-
els (6–9). In addition, TNF-  has been implicated in Th2
cell–mediated allergic diseases such as asthma and atopic der-
matitis (38–41). Therefore, IL-10 and TNF-  should not be
classified as either a Th2 or a Th1 cytokine. 
Similarly a recent study by Umetsu and colleagues (42)
defined a new type of Th1 cell–like regulatory T cells that
expressed both IFN-  and IL-10 and had the ability to in-
hibit airway hyper-reactivity. We therefore propose on the
basis of these findings that Th1 cells or Th2 cells be further
classified into a TNF- 2 IL-10  inflammatory subtype and a
TNF-  / IL-10  regulatory subtype (Fig. 8). OX40L ex-
pressed by DCs may convert TNF-  / IL-10  regulatory T
helper cells into TNF- 2 IL-10  inflammatory T helper cells
during both Th1 cell development (in the presence of IL-12)
or Th2 cell development (in the absence of IL-12) (Fig. 8).
In summary, we demonstrated that OX40L is the posi-
tive Th2 cell–polarizing signal from TSLP-DCs that induces
inflammatory Th2 cell responses, in conjunction with an IL-
12 default mechanism. We further showed that OX40L acts
as a switch that inhibits IL-10, but promotes TNF-  in both
Th1 and Th2 cell responses. These results may shed new
light on the unsolved paradoxes of Th2 cell biology and lead
us to propose that Th1 and Th2 cell responses can be di-
vided into inflammatory and regulatory subtypes.
MATERIALS AND METHODS
Isolation and culture of blood myeloid DCs. CD11c  DCs were iso-
lated from the buffy coat of blood from healthy adult volunteers, as de-
scribed previously (13, 43). In brief, the DC-enriched population (lineage 
cells) was obtained from PBMCs by negative immunoselection using a
mixture of mAbs against the lineage markers, CD3 (OKT3), CD14 (M5E2),
CD15 (HB78), CD20 (L27), CD56 (B159), and CD235a (10F7MN), fol-
lowed by using goat anti–mouse IgG-coated magnetic beads (M-450; Dynal
and Miltenyi Biotec). The CD11c , lineage , and CD4  cells were isolated
by a FACS Aria (BD Biosciences) by using allophycocyanin (APC)-labeled
anti-CD11c (B-ly6), a mixture of FITC-labeled mAbs against lineage mark-
ers, CD3 (HIT3a), CD14 (MØP9), CD15 (HI98), CD16 (3G8), CD19
(HIB19) and CD56 (NCAM16.2); and APC-Cy7-labeled CD4 (RPA-T4)
to reach  99% purity. CD11c  DCs were cultured in Yssel’s medium
(Gemini Bio-Products) containing 2% human AB serum. Cells were seeded
at a density of 2   105 cells/200  l medium in flat-bottomed 96-well plate in
the presence of 15 ng/ml TSLP (recombinant human TSLP had been pre-
pared in-house using an adenovirus vector system as described previously
[reference 13]), 25  g/ml of poly I:C (InvivoGen), or culture medium alone.
Microarray analysis and bioinformatics. Total RNA from DCs was
immediately isolated with the RNeasy kit from QIAGEN, and used to gen-
erate cDNA according to the Expression Analysis Technical Manual (Af-
fymetrix). cRNA samples were generated with the Bioarray High-Yield
RNA Transcript Labeling kit (ENZO) and Human Genome U133 plus 2.0
array according to the manufacturer’s protocol (Affymetrix). The scanned
images were aligned and analyzed using the GeneChip software Microarray
Suite 5.0 (Affymetrix) according to the manufacturer’s instructions. The signal
intensities were normalized to the mean intensity of all the genes represented
on the array, and global scaling (scaling to all probe sets) was applied before
performing comparison analysis. Genes with variable expression levels were
selected based on the following criteria: genes should be expressed (have pres-
ence calls) in at least one of the three samples and  i/ i ratio should be
 0.65, where  i and  i are the standard deviation and mean of the hybridiza-
tion intensity values of each particular gene across all samples, respectively.
An unsupervised hierarchical clustering algorithm by the software Cluster was
applied to group the three samples for Fig. 1 A based on the similarity of the
expression profiles of the selected genes. For genes represented by multiple
probe sets, results for only one representative probe set are shown. 
Real-time PCR.  Total RNA was extracted with the Qiagen RNeasy
mini protocol and was converted to cDNA using oligo-dT, random hex-
amers, and SuperScript RT II (Invitrogen). cDNA was diluted 1:10 and
real-time PCR was performed using a sequence detector (model ABI
PRISM 7500; PerkinElmer) and target mixes (TaqMan Assay-on-Demand
Gene expression reagents; Applied Biosystems): T-bet (Hs00203436_m1),
GATA 3 (Hs00231122_m1), c-Maf (Hs00286832_m1), and 18s
(Hs99999901_s1). Threshold cycle (CT) values for each gene were normal-
ized to 18s using the equation 1.8(18s-GENE) (10,000), where 18s was the
mean CT of triplicate 18s runs, GENE was the mean CT of triplicate runs of
the gene of interest, and 10,000 was an arbitrarily chosen factor to bring all
values above zero.
Analyses of OX40L expression. RT reactions were performed with Su-
perScript RT II. The DNA resulting from each RT reaction was then sub-
jected to PCR. The temperature profiles of the PCR were as follows: an
initial denaturation step at 94 C for 5 min; followed by 36 cycles at 94 C
for 1 min, 55 C for 1 min, and 72 C for 30 s; and then a final elongation
step at 72 C for 7 min. The sequences of primers were as follows: (for
Figure 8. Schematic illustration of Th1 and Th2 cell responses 
classified into inflammatory versus regulatory subtypes according 
to IL-10 and TNF-  expression. The figure depicts the hypothesis from 
our study. IL-4 and IL-12 are classic Th2 cell– and Th1 cell–polarizing 
factors, respectively. IL-4 and IL-12/IFN- /  induce conventional Th2 and 
Th1 cells, respectively, which produce IL-10. In contrast, OX40L from DCs 
promotes TNF- , but inhibits IL-10 production by the developing Th2 cells 
induced by IL-4 or Th1 cells induced by IL-12. These inflammatory Th2 and 
Th1 cells may contribute to the induction of allergic and autoimmune 
diseases, respectively.NOVEL FUNCTION OF OX40L EXPRESSED BY TSLP-ACTIVATED DCS | Ito et al. 1222
OX40L) forward, 5 -CCCAGATTGTGAAGATGGAA-3  and reverse,
5 -GCCTGGTTTTAGATATTGCC-3 ; and (for  -actin) forward, 5 -
CTGGAACGGTGAAGGTGACA-3  and reverse, 5 -AAGGGACTTCCT-
GTAACAATGCA-3 . To evaluate surface OX40L expression, CD11c  DCs
freshly isolated or after being cultured at different time points were stained
with PE-labeled anti-OX40L mAb (Ancell) or with an isotype-matched con-
trol mAb and then were analyzed by a FACSCalibur (BD Biosciences). 
CD4  T cell stimulation. CD4 CD45RA  naive T cells (purity  99%)
were isolated by using CD4  T cell Isolation Kit II (Miltenyi Biotec) fol-
lowed by cell sorting (as a CD4 CD45RA CD45RO-CD25- fraction). Af-
ter 24 h of culture under different conditions (medium alone, poly I:C, or
TSLP), CD11c  DCs were washed twice and cocultured with 2   104
freshly purified allogeneic naive CD4  T cells (DC/T ratio, 1:5) in round-
bottomed 96-well culture plates for 7 d. The T cells were also collected at
day 3 and 5 for real-time PCR analysis. In some experiments, CD4  T cells
primed with TSLP-DCs were subsequently recultured with TSLP-DCs
from the same allogeneic donor (DC/T ratio, 1:5) for further 7 d. In other
experiments, naive CD4  T cells were stimulated with 5  g/ml anti-CD3
mAb (OKT3) and 1  g/ml anti-CD28 mAb (CD28.2) in the presence of
irradiated OX40L-transfected L cells (16) or parental L cells, at a ratio of
1:4. Yssel’s medium containing 2% human AB serum was used for the T cell
cultures. We used the following neutralizing Abs and recombinant human
cytokines for our culture conditions: 50  g/ml anti-OX40L mAb (ik-5), 10
 g/ml anti–IL-4 mAb (MP4-25D2; BD Biosciences), 1  g/ml anti–IL-12
Ab (AF-219-NA; R&D Systems), 10  g/ml anti-CD40L mAb (LL2), 10
ng/ml recombinant human IL-12 (R&D Systems), and 25 ng/ml recombi-
nant human IL-4 (R&D Systems). Mouse IgG2a, rat IgG1, and goat IgG
(R&D Systems) were used as controls. In some experiments, naive T cells
were labeled with carboxyfluorescein diacetate succinimidyl ester (Invitrogen)
as described previously (43).
Analyses of T cell cytokine production. After one cycle of stimulation
(for 7 d) or two cycles of stimulation (for total 14 d) by the DCs or anti-
CD3 and anti-CD28 mAbs (for 7 d), the primed CD4  T cells were col-
lected and washed. For detection of cytokine production in the culture
supernatants, the T cells were restimulated with plate-bound anti-CD3
(OKT3, 5  g/ml) and soluble anti-CD28 (1  g/ml) at a concentration of
106 cells/ml for 24 h. The levels of IL-4, IL-5, IL-10, IL-13, TNF- , and
IFN-  were measured by ELISA (all kits from R&D Systems). For intracel-
lular cytokine production, the primed CD4  T cells were restimulated with
50 ng/ml of PMA plus 2  g/ml of ionomycin for 6 h. Brefeldin A (10  g/
ml) was added during the last 2 h. The cells were stained with the combina-
tion of PE-labeled mAbs to IL-4, IL-5, IL-10, IL-13, IFN- , or TNF- ,
FITC-labeled anti–IFN-  or anti–TNF- , and APC-labeled anti–IL-10 or
Alexa Fluor 647-labeled anti–IL-4 (all from BD Biosciences) using FIX and
PERM kit (CALTAG). 
Online supplemental material. Tables S1–S4 show the datasets from
four independent experiments related to Figs. 2 (C and D) and 6 (A and B),
respectively. Dataset of experiment 1 in each table was shown as Figs. 2 (C
and D) and 6 (A and B). Data are shown as percentages of the respective cy-
tokine-producing T cells (Tables S1 and S3) and as means of triplicate cul-
tures evaluated by ELISA (Tables S2 and S4). Online supplemental material
is available at http://www.jem.org/cgi/content/full/jem.20051135/DC1.
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